Study on the Slow-release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis.

CONCLUSION: This study shows that the microspheres prepared in this study have sufficient ability of stable drug release at least 35 days, with good efficacy and high safety. In addition, mometasone furoate can be used as a potential candidate drug for 35 day long-term injection. PMID: 32940181 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32940181?dopt=Abstract

Source: Current Drug Delivery - September 16, 2020 Category: Drugs & Pharmacology Authors: Liang Y, Zhang J, Zhao X, Wang M, Ding S, Wang Y, Chen Y, Liu J Tags: Curr Drug Deliv Source Type: research